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Decreased IL7Rα and TdT 
expression underlie the skewed 
immunoglobulin repertoire of 
human B-cell precursors from fetal 
origin
Magdalena B. Rother1, Kristin Jensen2,3, Mirjam van der Burg1, Fleur S. van de Bovenkamp1, 
Roel Kroek1, Wilfred F.J. van IJcken4, Vincent H.J. van der Velden1, Tom Cupedo5, 
Ole K. Olstad2,3, Jacques J.M. van Dongen1 & Menno C. van Zelm1,6
Newborns are unable to mount antibody responses towards certain antigens. This has been related 
to the restricted repertoire of immunoglobulin (Ig) genes of their B cells. The mechanisms underlying 
the restricted fetal Ig gene repertoire are currently unresolved. We here addressed this with detailed 
molecular and cellular analysis of human precursor-B cells from fetal liver, fetal bone marrow (BM), 
and pediatric BM. In the absence of selection processes, fetal B-cell progenitors more frequently used 
proximal V, D and J genes in complete IGH gene rearrangements, despite normal Ig locus contraction. 
Fewer N-nucleotides were added in IGH gene rearrangements in the context of low TdT and XRCC4 
expression. Moreover, fetal progenitor-B cells expressed lower levels of IL7Rα than their pediatric 
counterparts. Analysis of progenitor-B cells from IL7Rα-deficient patients revealed that TdT expression 
and N-nucleotides additions in Dh-Jh junctions were dependent on functional IL7Rα. Thus, IL7Rα 
affects TdT expression, and decreased expression of this receptor underlies at least in part the skewed Ig 
repertoire formation in fetal B-cell precursors. These new insights provide a better understanding of the 
formation of adaptive immunity in the developing fetus.
During the second trimester of human fetal development, B cells are generated in the liver and bone marrow 
(BM), providing the neonate with a diverse immunoglobulin (Ig) repertoire. Still, antibody responses towards 
certain antigens (e.g. tetanus or diphtheria toxoid) are impaired in neonates, and the ability to respond is only 
acquired with age1–3. Various processes can underlie this initial inability to mount such responses, including a 
“pre-mature” diversity of the Ig repertoire.
B-cell development has been extensively studied in human postnatal BM, where 5 distinct stages can be iden-
tified. In the early pro-B and pre-BI cell stages, D to J gene rearrangements and V to DJ gene rearrangements 
are induced by the lymphoid-specific recombination activating gene proteins 1 and 2 (Rag1 and Rag2) in the Ig 
heavy chain (IGH) locus4,5. Subsequently, the cells induce V to J gene rearrangements in their Ig light chain loci 
(IGK or IGL) as pre-B-II small cells and the complete Ig molecule is selected for functionality at the immature-B 
cell stage6,7. The Rag-induced double stranded DNA breaks activate cell cycle checkpoint protein ATM and the 
non-homologous end joining (NHEJ) pathway8–10, which enhances diversity in the junctional region that encodes 
the antigen-binding complementary determining region (CDR)3. A central player is the lymphoid-specific deox-
ynucleotidyl transferase protein (TdT) that randomly adds N-nucleotides to the junction11–13.
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Several studies have addressed the Ig gene repertoire in human fetuses, and reported restricted repertoires 
due to shorter CDR3 regions in IGH. This restriction was the result of limited N-nucleotides in the junctions and 
more frequent usage of the relatively short Dh7-27, Jh2 and Jh3 genes1,2,14–23. Finally, the Dh-proximal Vh6-1 and 
Vh1-2 genes appear to be more frequently used in fetal B cells1,24–27.
Similar skewing of the IGH gene repertoire has been observed in mouse embryos14,15,18,19. Embryonic B-cell 
progenitors in the mouse liver have been shown to generate a separate B-cell lineage, and can develop independ-
ent of functional IL7R signaling28,29. Postnatal B-cell development in IL7R-deficient mice is completely blocked 
due to defects in proliferation and survival29,30. Furthermore, IL7R-deficient progenitor-B cells are impaired in 
the capacity to rearrange DJh-distal Vh genes31. In contrast to mouse, human B cells can develop in the absence 
of IL7R signaling32,33. However, the Ig gene repertoire in progenitor-B cells of IL7Rα -deficient patients has not 
been studied so far. Thus, it remains unclear what underlies the skewed Ig repertoire in fetal B cells and if IL-7R 
signaling is involved.
We here studied the nature of Ig gene repertoire formation during human fetal B cell development in 
B-cell progenitors, and the role of IL7Rα in this process. Through analysis of patients with genetic defects in 
IL7Rα, we were able to demonstrate a direct link between IL7Rα , TdT and N-nucleotide additions in IGH gene 
rearrangements.
Results
Skewed Ig repertoire generation in fetal B cell precursors. To study the Ig repertoire formation in 
fetal development, we purified B-cell subsets from 2nd trimester fetal BM and fetal liver, as well as from neonatal 
cord blood and pediatric BM. In line with previous observations1,16,17,20,21,24,25,27,34, mature B cells (CD19+ CD20+ 
CD10-IgM+ IgD+ ) in fetal BM showed more frequent usage of Vh1-2, Dh7-27, Jh2 and Jh3 genes than pediatric 
B cells (Supplementary Fig. 1)23. This IGH gene usage was typical for early development, because the IGH reper-
toire in B cells from neonatal cord blood was more similar to pediatric than to fetal B cells (Supplementary Fig. 1). 
Moreover, CD19+ CD34+ CD10+ pre-BI cells derived from either fetal liver or fetal BM contained the same 
skewed IGH repertoire (Fig. 1A–C). These pre-BI cells initiate Vh to DJh gene rearrangements, but do not yet 
express cytoplasmic IgM and are not selected for functional IGH genes35. This was supported by analysis of only 
the out-of-frame and thus unproductive IGH gene rearrangements (Supplementary Fig. 2A–C). Approximately 
1/3rd of the pre-BI cells carried in-frame and thereby potentially productive IGH gene rearrangements (31% in 
fetal liver, 29% in fetal BM and 33% in pediatric BM). Thus, fetal B-cell progenitors are generated with a skewed 
IGH gene repertoire, which is similar between fetal liver and fetal BM, and does not seem to be affected by selec-
tion processes.
In contrast to IGH, the IGK gene repertoire was not different between fetal and pediatric mature B cells nor 
small pre-BII cells (Supplementary Figs 3 and 4). Because the vast majority of IGK gene rearrangements are 
formed in small pre-B-II cells, the formation and selection processes for the IGK repertoire do not seem to differ 
between pediatric and fetal B-cell development.
Figure 1. Skewed Ig repertoire generation in fetal B cell precursors. (A) IGHV, (B) IGHD, (C) IGHJ gene 
usage in pre-BI cells from fetal liver, fetal BM and pediatric BM. In-frame and out-of-frame rearrangements 
were included. 102 sequences were derived from fetal liver (3 donors), 148 from fetal BM (4 donors) and 160 
from pediatric BM (5 donors). Statistics: χ 2 test; *p < 0.05, ***p < 0.001, ****p < 0.0001.
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Short Dh genes and fewer N-nucleotides in fetal B cells. In addition to the skewed V, D and J gene 
usage, IGH gene rearrangements in fetal naive mature B cells carried shorter IgH-CDR3 than pediatric B cells 
(Fig. 2A)1,2,16,17,20,21,36. This was mostly the result of fewer N-nucleotide additions in both the Dh-Jh and Vh-DJh 
junctions (Fig. 2B), as well as high usage of the short Dh7-27 gene (Supplementary Fig. 1). The IgH-CDR3 of B 
cells from neonatal cord blood were intermediate in size between fetal and pediatric B cells with slightly more 
N-nucleotides in the Vh-DJh junction than fetal B cells. Both in fetal and in pediatric tissue, the IgH-CDR3 
regions in pre-BI cells were larger than in naive mature B cells. Still, fetal pre-BI carried shorter IgH-CDR3 with 
fewer N-nucleotides than their pediatric counterparts (Fig. 2B, Supplementary Fig. 2D,E, Supplementary Table 1).
In addition to junctional region processing, the IgH-CDR3 size is affected by the Dh gene usage as these differ 
greatly in size. Indeed, the Dh7-27 gene that was abundantly found in fetal B cells is the shortest of all D genes. In 
addition, the large Dh genes were less frequently observed in fetal than in pediatric B cells (Supplementary Fig. 5a,b). 
Still, as previously suggested16, N-nucleotide additions seem dependent on Dh gene usage. The incomplete Dh-Jh 
rearrangements involving the short Dh7-27 carried more N-nucleotides than rearrangements involving any other 
Dh gene families (Supplementary Fig. 5c). Finally, the shorter IgH-CDR3 in naive mature B cells than in pre-BI 
cells (Fig. 2) was associated with selection against long Dh genes. Thus, the IgH-CDR3 size seems tightly regulated 
through N-nucleotide additions and Dh gene usage, which differ between fetal and pediatric B-cell progenitors.
In contrast to IGH, the IGK locus does not contain D genes, and Vκ -Jκ gene rearrangements hardly contain 
any N-nucleotide, thus rendering small CDR3 regions. Indeed, the Igκ -CDR3 regions of the fetal, neonatal and 
pediatric B-cell subsets were much smaller than IgH-CDR3 and did not show overt differences between any of 
the subsets (Fig. 2A, Supplementary Table 2). Although the pediatric naive mature B cells tended to have more 
N-nucleotide additions (Fig. 2B), there was no indication of a different Igκ -CDR3 repertoire in fetus.
B cells in BCP-ALL of presumed fetal origin show fetal Ig repertoire characteristics. Our data 
indicate that normal B-cell precursors from fetal tissue differ from children. To study whether these cellular and 
molecular differences were retained in a disease model, we analyzed the IGH gene repertoire in BCP-ALL samples. 
BCP-ALL with MLL rearrangements or with TEL-AML1 fusion genes can originate in utero37–40. We compared 
the IGH gene repertoire of these presumed fetal BCP-ALL subgroups and with the rest, i.e. subgroups containing 
E2A-PBX translocations, BCR-ABL translocations, hyperdiploidy or none of these abnormalities. The average 
age in years at diagnosis was 0.65 ± 0.68 for MLL rearranged BCP-ALL and 4.85 ± 2.95 for TEL-AML1-positive 
BCP-ALL, while the non-fetal origin group aged 6.39 ± 4.18.
The BCP-ALL of presumed fetal origin indeed showed increased usage of the Dh-proximal Vh6-1 gene, sim-
ilar to fetal B cells (Fig. 3A). In contrast, the usage of Dh and Jh genes did not differ between the BCP-ALL 
patients of presumed fetal and non-fetal origin (Fig. 3B,C). Still, BCP-ALL of presumed fetal origin showed a 
trend to less frequently use long Dh genes than the other BCP-ALL (Supplementary Figs 5a and 6a), and the 
IgH-CDR3 length was shorter in BCP-ALL of presumed fetal origin. The latter was due to significantly fewer 
N-nucleotides in Dh-Jh junctions (Fig. 3D,E, Supplementary Table 1), and equally apparent in BCP-ALL with 
MLL-rearrangements and with TEL-AML1 translocations (Supplementary Fig. 6b,c).
Figure 2. Fetal B cells have short IgH-CDR3 regions and few N-nucleotides. (A) CDR3 length of complete 
IGH and IGK gene rearrangements. Grey dots represent unique clones, black lines median values. (B) The 
median numbers of N-nucleotides in Dh-Jh, Vh-DJh and Vκ -Jκ junctions with inter-quartile range. Numbers 
of analyzed sequences in brackets. In-frame and out-of-frame rearrangements were included in the analysis of 
precursor-B cells, whereas only in-frame rearrangements for naive mature-B cells. Statistics: Mann-Whitney U 
test; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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Concluding, these observations in BCP-ALL confirm and extend our results that the IGH gene repertoire 
differences between fetus and child are the result of altered V(D)J recombination processes in early progenitors 
rather than Ig repertoire selection processes in mature B cells.
Enrichment of early B-cell precursors in fetal liver and BM. To study the nature of the skewed IGH 
gene repertoire generation in prenatal development, we first analyzed the precursor-B cells in fetal liver and BM 
in more detail by flow cytometry. The relative distributions of the five major precursor-B-cell subsets in these 
fetal tissues were determined using a panel of membrane and intracellular markers and compared with pediatric 
BM (Fig. 4A)41,42. The frequencies of the pro-B, pre-BII large and pre-BII small within the total CD22+ B-cell 
precursors were similar between fetal liver and fetal BM. Fetal livers contained on average less pre-BI and more 
immature-B cells, but these differences were not significant. Both fetal tissues contained more CD34+ precursors 
than pediatric BM (Fig. 4B). This was mostly the result of increased pro-B cell frequencies (~12% vs 4%), and was 
to the expense of reduced pre-BII large frequencies (~10% vs 20%).
IGH locus contraction in fetal precursor-B cells. Previous studies have shown large-scale contraction 
of the IGH locus in mouse pro-B cells and the corresponding human pre-BI cells that facilitate rearrangements 
involving Dh-distal Vh genes43–47. Thus, the skewed Ig repertoire formation and developmental shift observed 
in fetus at pro-B/pre-BI stage could potentially result from inefficiently formed IGH gene rearrangements due to 
aberrant IGH locus topology. To study whether the IGH topology provided optimal conditions for V(D)J recom-
bination, we measured spatial distances between distal Vh, proximal Vh, and Ch regions with 3D DNA FISH 
in precursor-B cells of fetal and pediatric BM (Fig. 5A). In line with our previous studies44,46, spatial distances 
between all three DNA regions were short in pediatric pre-BI cells and slightly, yet significantly, larger in pediatric 
pre-BII small cells (Fig. 5B,C). IGH locus contraction did not seem defective in fetal pre-BI cells, as all spatial dis-
tances between Ch and both Vh regions were similarly small and distances between both Vh regions were even 
smaller than in pediatric pre-BI cells. IGH locus contraction is therefore likely to facilitate rearrangement of both 
proximal and distal Vh gene rearrangements similarly between fetal and pediatric B-cell precursors and it does 
not provide further insight into the relative abundance of Vh1-2 in the fetal IGH gene repertoire.
Figure 3. BCP-ALL of presumed fetal origin show fetal Ig repertoire characteristics. (A) IGHV, (B) IGHD, 
(C) IGHJ gene usage in IGH gene rearrangments. (D) IgH-CDR3 length. Grey dots represent unique clones, 
black lines median values. (E) Median numbers of N-nucleotides in Dh-Jh and Vh-DJh junctions with inter-
quartile range. In-frame and out-of-frame rearrangements were included. The numbers of sequences are 
indicated between brackets. Statistics: χ 2 (panels A/B/C), or Mann-Whitney (panels D/E); *p < 0.05, **p < 0.01, 
***p < 0.001, ****p < 0.0001.
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Mechanisms causing formation of skewed Ig repertoire in fetuses. To delve deeper into the mecha-
nism responsible for generation of the different Ig repertoires between fetal and pediatric early B-cell progenitors, 
we performed genome-wide gene expression profiling of fetal and childhood B-cell progenitors (Supplementary 
Fig. 7A). The analysis was performed in fetal pro-B and pre-BI cells, which were compared to previously pub-
lished childhood subsets44, and was focused on genes important for B-cell development and V(D)J recombination 
to provide insights into the molecular environment in which Ig gene rearrangements are formed.
The expression of RAG1 and RAG2 was similar between fetus and child for both pro-B and pre-BI cells. The 
genes encoding key B-cell transcription factors E2A, EBF1 and PAX5 were also highly expressed in fetal progen-
itors, as was FOXO1, which regulates RAG gene expression48,49. These data are in line with the diverse IGH gene 
repertoire in fetus. Furthermore, the genes encoding pre-BCR signaling components were normally expressed 
and did not seem rate-limiting for differentiation into pre-BII cells (Table 1).
However, the components of the DNA damage response pathways were downregulated in fetuses as compared 
to children. Among these was ATM (Table 1 and Supplementary Fig. 7b), which has a critical role in cell cycle 
arrest and recruitment of DNA repair factors to the broken ends8,9,50,51. Furthermore, the gene encoding XRCC4 
that is part of the NHEJ pathway required for repair of Rag-induced DNA breaks10, was downregulated in fetal 
cells (Table 1 and Supplementary Fig. 7b). XRCC4 forms a protein complex with TdT, the enzyme responsible for 
N-nucleotide additions, and it was shown that XRCC4 promotes N-nucleotides addition by TdT52. Importantly, 
we also observed decreased expression of DNTT, which encodes TdT (Table 1). Additional intracellular TdT 
staining by flow cytometry revealed that these decreased transcripts resulted in decreased protein levels in both 
pro-B and pre-BI in fetuses (Fig. 6A).
In addition to DNA repair, the components of signaling pathways which increase accessibility of Ig loci for 
rearrangements were downregulated in fetus. IL-7R signaling affects IGH gene rearrangements and inhibits IGK 
gene rearrangements46,53,54. Fetal pro-B cells showed low expression of IL7RA transcripts and membrane proteins 
(Table 1 and Fig. 6B). Moreover, transcripts encoding the IL-7R signaling molecule JAK2 were reduced in pro-B 
cells, whereas transcripts of ID2 and germline IGK that are normally suppressed by IL-7R signaling55–57 were 
upregulated (Table 1). The decreased IL-7Rα expression did not seem to affect proliferation because transcripts 
nor nuclear Ki-67 protein were different between fetuses and children (Table 1 and Fig. 6C). Fms-related tyrosine 
kinase-3 (FLT3) was also downregulated in fetal pro-B cells (Table 1 and Fig. 6D). This is the receptor for FLT3L 
that has synergistic effects with IL-7 on survival and proliferation of B-cell progenitors58.
Together, fetal B-cell progenitors differ from their pediatric counterparts in expression levels of NHEJ compo-
nents and TdT, as well as surface receptors IL-7R and FLT3.
TdT expression and N-nucleotide additions in IL7Rα-deficient patients. Ingenuity pathway anal-
ysis suggests that IL-7R and FLT3 signaling interact with the NHEJ pathway (Fig. 7A, Supplementary Fig. 8), 
and that these proteins regulate expression of TdT and N-nucleotide insertions in postnatal B-cell precursors. To 
confirm this relation, we tested the effects of lack of IL7R signaling: B-cell precursors from IL7Rα -deficient chil-
dren. If IL7R signaling is important for TdT expression and N-nucleotide additions in postnatal B-cell precursors, 
IL7Rα -deficient B-cells should be defective in both. CD79A+ CD19- BM-derived pro-B cells of IL7Rα -deficient 
children showed lower nuclear TdT protein levels than healthy children (Fig. 7B). Out-of-frame IGH gene rear-
rangements in B cells of these patients contained fewer N-nucleotides in the Dh-Jh junctions (Fig. 7C). Since 
Figure 4. Relative increase of early precursor-B cells in fetus. (A) Gating strategy to define 5 precursor B-cell 
subsets according to previous studies35,42. (B) Relative distributions of the 5 precursor-B-cell subsets in fetal 
liver, fetal BM and pediatric BM. Statistics: Mann-Whitney U test; *p < 0.05, ****p < 0.0001.
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these Dh-Jh junctions were generated in pro-B cells35, and were not subjected to selection processes, this con-
firms that functional IL-7R expression affects IGH junction processing.
Discussion
In the present study, we showed that during fetal development a diverse Ig repertoire is formed. Still, this reper-
toire is skewed with regards to combinatorial diversity. IgH-CDR3 regions were shorter due to fewer N-nucleotide 
addition, and this was directly associated with reduced TdT and IL7Rα expression. Indeed, TdT expression and 
N-nucleotide additions were affected in B cells of patients with genetic defects in IL7RA. Thus, we here provide 
the first link between IL7Rα with IGH gene rearrangements in man, as well as a role for IL7Rα in the differences 
between fetal and childhood Ig gene repertoires.
The fetal Ig repertoire has been a subject of study for the past 3 decades1,2,16,17,20,21,24–27,34. Reported differences 
with postnatal B cells include V, D, and J gene usage, as well as N-nucleotide additions1,16,17,20,34. Still, not all 
findings were consistent, and several studies reported different findings1,24,34. We acknowledged the apparent 
difficulties in the assessment of the fetal Ig repertoire, and took a two-step approach to tackle these. First, we 
assessed the repertoire in single-sorted naive mature B cells, thereby avoiding potentially preferential PCR-based 
amplification of V genes. Consequently, we obtained an unbiased view of the naive B cell-repertoire23. Secondly, 
we amplified IGH and IGK gene rearrangements from early precursors that had not yet been selected for in-frame 
rearrangements35. This approach allowed us to study which of the characteristics in the mature repertoire were 
the result of altered V(D)J recombination processes rather than selection. Thus, we confirmed that the fetal naive 
mature Ig repertoire contained more Vh1-2, Dh7-27, Jh2 and Jh3 genes than pediatric B cells1,16,17,20. The high 
frequencies of Dh7-27 and Jh2 and Jh3 could in part be the result of absence of secondary rearrangements involv-
ing upstream Dh and downstream Jh genes. However, other than Dh7-27 usage, we did not see trends for rear-
rangements between upstream Dh and downstream Jh genes (not shown). Despite the high Vh1-2 usage, the 
Figure 5. IGH locus contraction in fetal and pediatric B-cell precursors. (A) The human IGH locus with 
details of BAC clones used as 3D FISH probes44,46. (B) Spatial distances separating distal Vh, proximal Vh, 
and Ch regions in precursor-B cells from fetal and pediatric BM. Grey dots represent individual alleles, red 
bars median values. Per group, > 200 alleles from 2 donors were analyzed. Statistics: Mann–Whitney U test; 
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. (C) Representative images of stained IGH loci.
www.nature.com/scientificreports/
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Pro-B Pre-BI
Mean 
fetus
Mean 
child
Fold 
change p-value
Mean 
fetus
Mean 
child
Fold 
change p-value
transcription factors / 
B-cell commitment 
E2A (TCF3) 226.09 154.98 1.5 0.02 259.49 209.27 1.2 0.02
ID2 121.79 43.51 2.8 0.23 195.40 80.31 2.4 0.03
EBF1 389.42 876.11 − 2.3 0.33 1182.40 1090.52 1.1 0.12
PAX5 257.97 189.37 1.4 0.52 618.04 456.95 1.4 0.02
HEB (TCF12) 87.07 224.12 − 2.6 0.07 204.00 279.67 − 1.4 0.01
PU.1 (Spi1) 90.22 57.57 1.6 <0.01 91.75 72.83 1.3 0.06
Foxo1 182.02 167.64 1.1 0.56 231.92 224.62 1 0.58
IRF4 99.81 81.96 1.2 0.45 140.36 135.16 1 0.87
IRF8 106.55 48.62 2.2 0.03 113.48 74.69 1.5 0.02
IKZF1 (Ikaros) 86.01 151.17 − 1.8 0.05 201.46 172.66 1.2 0.25
IKZF2 (Helios) 59.77 65.55 − 1.1 0.77 248.02 277.30 − 1.1 0.66
IKZF3 (Aiolos) 21.92 17.95 1.2 0.43 58.31 76.44 − 1.3 0.32
V(D)J/DNA repair
RAG1 103.62 121.84 − 1.2 0.47 165.91 150.29 1.1 0.39
RAG2 113.90 209.38 − 1.8 0.43 227.32 309.86 − 1.4 0.05
XRCC5 (Ku80) 186.08 554.95 − 2 0.15 606.18 725.66 − 1.2 0.04
XRCC6 (Ku70) 44.06 39.20 1.1 0.50 48.62 31.89 1.5 0.09
DNA-PKcs (PRKDC) 60.68 196.41 − 3.2 0.01 149.73 290.76 − 1.9 0.02
Artemis (DCLRE1C) 41.31 71.56 − 1.7 0.02 87.42 121.32 − 1.4 0.03
XRCC4 31.30 80.04 − 2.6 0.049 79.37 124.96 − 1.6 0.049
XLF (NHEJ1) 51.80 49.12 − 1.1 0.26 54.44 49.08 1.1 0.14
LIG4 243.02 300.93 − 1.2 0.84 746.53 472.78 1.6 0.14
TdT (DNTT) 399.84 1693.51 − 4.2 0.17 1111.20 1656.59 − 1.5 0.02
pol λ 47.36 31.85 1.5 0.15 33.68 31.84 1.1 0.52
pol μ 85.47 55.48 1.5 0.02 74.14 58.40 1.3 0.05
ATM 48.57 166.38 − 3.4 0.04 106.49 199.37 − 1.9 0.01
MRE11A 41.67 169.07 − 4.1 0.02 96.98 212.86 − 2.2 <0.01
NBS (NBN) 43.04 174.16 − 4.1 0.02 85.99 178.98 − 2.1 0.02
Rad50 96.36 290.60 − 3 0.15 264.57 326.31 − 1.2 0.049
pre-BCR signaling
CD22 83.09 64.89 1.3 0.18 545.90 295.23 1.9 <0.01
CD19 117.52 68.81 1.7 0.01 138.91 82.83 1.7 <0.01
CD34 210.88 295.12 − 1.4 0.42 329.68 268.36 1.2 0.48
CD10 217.69 969.99 − 4.5 0.15 880.24 1275.02 − 1.5 0.03
CD79A 150.68 139.54 1.1 0.86 268.79 143.01 1.9 <0.01
CD79B 183.05 103.54 1.8 0.27 228.40 158.76 1.4 0.05
VPREB1 297.75 501.40 − 1.7 0.49 778.90 644.68 1.2 0.18
λ 14.1 (IGLL5) 38.86 29.63 1.3 0.10 36.88 35.34 1 0.24
BTK 106.92 142.97 − 1.3 0.50 193.35 183.15 1.1 0.64
SYK 106.83 170.55 − 1.6 0.23 208.60 219.74 − 1.1 0.14
BLNK 284.80 812.93 − 2.9 0.20 696.87 672.31 1 0.68
IGHG1 89.03 65.57 1.4 < 0.01 110.02 82.20 1.3 0.01
IGKC 137.41 54.08 2.5 0.09 313.73 192.59 1.6 0.10
IL2RG 100.12 238.93 − 2.4 0.05 174.79 155.79 1.1 0.28
proliferation/survival
Ki− 67 (MKI67) 182.64 305.69 − 1.7 0.39 689.30 833.39 − 1.2 0.24
IL7Rα 44.38 171.98 − 3.9 0.04 169.35 150.13 1.1 0.75
LEF1 258.38 355.16 − 1.4 0.7 893.34 1002.85 − 1.1 0.03
STAT5A 80.84 67.61 1.2 0.23 89.54 77.34 1.2 0.06
STAT5B 66.58 92.58 − 1.4 0.09 85.84 90.19 − 1.1 0.43
JAK1 170.76 303.35 − 1.8 0.35 419.79 366.42 1.2 0.01
JAK2 38.05 81.16 − 2.1 <0.01 39.67 76.44 − 1.9 0.07
JAK3 61.46 42.30 1.5 0.06 60.12 48.21 1.3 0.02
TYK2 77.17 56.01 1.4 0.049 75.25 64.44 1.2 0.64
FLT3 34.20 279.61 − 8.2 0.01 64.21 157.15 − 2.5 0.30
c-KIT 35.86 73.68 − 2.1 0.03 31.01 32.66 − 1.1 0.02
Table 1.  Gene expression profiling of fetal and pediatric precursor-B cells. Expression levels are shown as 
mean signal values. Differences in gene expression levels between fetus and child which showed p < 0.05 and 
fold change > 1.5 are marked in bold. Statistical significance was calculated with one-way ANOVA test. Gene 
expression profiling was performed on pro-B and pre-BI cells purified from 3 fetal BM and 4 pediatric BM 
donors.
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Dh-proximal Vh genes were in general not more frequently used in the human fetal repertoire24–26, in contrast to 
the mouse14,15,18,19. Importantly, we now established that these changes in the IGH gene repertoire were primarily 
the result of altered V(D)J recombination, and not due to changes in Ig repertoire selection.
The skewed IGH gene repertoire in fetus did not seem to result from changes in chromatin organization as the 
IGH locus in fetal B-cell precursors was contracted to a similar extent as in children. Moreover, critical transcrip-
tion factors for this process, such as E2A and Pax5 were highly expressed. The 3D spatial organization could thus 
support the utilization of diverse Vh genes in fetal B-cell precursors independent of genomic proximity to the 
Dh-Jh-Ch region14,15,18,19. It is possible that the Vh1-2, Dh7-27, Jh2 and Jh3 genes were more efficiently recom-
bined due to their optimal RSS sequences (www.imgt.org). However, RAG gene expression was equally high in 
both fetal and pediatric B-cell progenitors, making it difficult to understand how these could be rate-limiting in 
fetus. Alternatively, the Vh1-2 gene promoter activity could be affected by B-cell intrinsic or extrinsic factors. A 
likely candidate pathway would be IL-7R signaling that is known to affect IGH locus activity46,59. We were unable 
to study the production of IL-7 in fetal or pediatric BM, but we did find evidence for reduced IL-7Rα expression 
and lower IL-7R signaling in fetal B-cell progenitors, indicating that specific changes in Vh gene usage could 
be the result of altered susceptibility to IL-7. Furthermore, we observed increased usage of the Vh1-2 gene in 
out-of-frame rearrangements from IL-7Rα -deficient patients (not shown). This would suggest a similar role for 
IL-7R signaling in human as in mouse B-cell precursors, as the latter were found to be impaired in the capacity to 
rearrange DJh-distal Vh genes when IL7R was defective31.
We found additional evidence for differences in the generation of IGH gene rearrangements in fetal precur-
sors through analysis of BCP-ALL. ALL cases with MLL rearrangements or TEL-AML1 translocations can arise 
already during fetal development. Although not all cases will actually have a prenatal origin, our comparison of 
these cases with other BCP-ALL subsets confirmed previously observed paucity of N and P nucleotides in IGH 
junctions in ALL cells in neonatal blood spots60 and low TdT transcript levels in MLL-rearranged BCP-ALL61. 
Furthermore, we report similar changes in the Vh, Dh and Jh gene usage as in normal fetal B-cell precursors. 
Considering the distinct gene expression repertoires between fetal and postnatal B-cell precursors, our observa-
tions in BCP-ALL indicate that those of in utero origin will be derived from distinct precursors than other ALL. 
Thus, it is possible that the differences between BCP-ALL subsets will not only be determined by their genetic 
abnormalities, but also by their origin from fetal or postnatal precursor-B cells.
Through analysis of precursor-B cells, we could defined the cause of the reported reduction in N-nucleotides 
in IGH gene rearrangements1,17,20,22,34. Fetal precursor B cells expressed low levels of TdT, the enzyme that 
inserts these during NHEJ, as well as XRCC4, the NHEJ factor that directly affects TdT function52. Moreover, we 
could link the reduced TdT expression to the low expression of IL7Rα , as our analysis of precursor B cells from 
IL7Rα -deficient patients revealed low TdT expression and reduced N-nucleotide additions in D-Jh junctions. 
This is the first evidence for a role of IL7Rα in human IGH gene rearrangements. In mouse models, precursor 
B cells in postnatal BM completely depend on IL7Rα signaling, and IL7R-deficient cells show defects in IGH 
gene rearrangements, proliferation and survival29–31. Following the identification of similar roles for human and 
mouse IL7Rα in preventing premature IGK gene rearrangements46,62, it now appears that the function of IL7Rα 
in human and mouse B-cell precursors is more similar than has been previously appreciated.
Despite complete absence of a functional IL-7R, IL7Rα -deficient patients showed more N-nucleotide addi-
tions in IGH than fetal progenitor-B cells that still expressed low levels of IL-7Rα . It is unlikely that this is due 
to separate effects of IL-7 and TSLP, as IL7Rα is a crucial component for the receptors of both cytokines63,64. 
However, FLT3L can support the development of B cells in absence of IL7Rα 28, and acts in synergy with IL-7R to 
expand the hematopoietic progenitors58. The combined reduction in expression of both the receptor for FLT3L, 
FLT3, and IL7Ra in human fetal B-cell precursors might have a stronger impact on TdT and XRCC4 function 
than in IL7Rα -deficient patients.
A potential explanation can be derived from studies in TdT deficient mice65. In a competitive setting with 
TdT-proficient B-cell precursors, TdT-deficient B cells developed quicker and demonstrated an advantage in pop-
ulating peripheral lymphoid tissues. Through low TdT expression, the developing fetus would thus be able to 
provide a fast wave of B cells. Decreased ATM expression likely further enhanced expansion of early progenitor-B 
cells in fetus with less strict processing of IGH junctions. Considering the low levels of TdT in fetal thymus66–69, 
and the low numbers of N-nucleotides in TRB junctions22, it is likely that similar mechanisms apply for T cells. 
In addition to relatively fast generation, the shorter CDR3 regions could equip the early waves of B cells with a 
relevant autoreactive repertoire to assist in clearance of apoptotic cells36. How the IL7Rα expression levels are reg-
ulated to mediate between a fast and skewed versus a more random repertoire remains to be determined. A likely 
mechanism would be the amount of FLT3L produced by stromal cells, as FLT3 signaling is shown to enhance 
IL7Rα expression levels70.
Taken together, we here showed that the skewed IGH gene repertoire of fetal B cells is the result of altered 
V(D)J recombination in progenitor B cells rather than repertoire selection. Specifically, IGH gene rearrangements 
contained fewer N-nucleotide additions due to low XRCC4 and TdT expression in fetal pro-B and pre-BI cells. 
Since fetal B-cell progenitors expressed low levels of IL7Rα , and TdT expression was found to be directly linked to 
functional IL7Rα , we here provide the first evidence for a role of IL7Rα in human IGH gene repertoire formation. 
These new insights into precursor-B cell development could contribute to a better understanding of the formation 
of adaptive immunity in the developing fetus.
Methods
Tissue sampling and flow cytometry. The use of human fetal tissue (3 fetal liver and 9 fetal BM donors) 
and pediatric tissue (12 pediatric BM donors), and cord blood (4 donors) was approved by the Medical Ethical 
Committees of the Erasmus MC and Eastern Norway, and was contingent on informed consent in accord-
ance with the Declaration of Helsinki and the Dutch Fetal tissue act. Fetal tissues were obtained from elective 
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abortions, and informed consent was obtained after the decision to abort was finalized. Inclusion in the study 
did not affect the treatment regime in any way, and did not involve any form of payment. Gestational ages of 
the fetuses ranged between 15 and 19 weeks, and no abnormalities were present that could potentially affect the 
immune-repertoire. PBMC and BM B cells from 3 IL7Rα -deficient patients aged 3-9 months were obtained from 
left-over material of diagnostic work-up.
All methods were carried out in accordance with guidelines and regulations of the Immunology Department, 
Erasmus MC.
Flow cytometric immunophenotyping and purification of B-cell subsets from pediatric BM aspirates, fetal 
limb BM suspensions and fetal liver homogenates were performed as described previously (see Supplementary 
Methods)35,44.
Ig gene rearrangements and IGH locus contraction. Complete IGH and IGK gene rearrangements 
were amplified from DNA of bulk-sorted pediatric and fetal pre-BI and pre-BII small cells35,71, pre-BI cells of 
IL-7Rα -deficient patients and from umbilical cord blood mononuclear cells (Supplementary Table 3), cloned 
into the pGEM-T Easy vector (Promega Benelux BV, Leiden, The Netherlands) and sequenced. From RNA of 
single-cell sorted naive mature-B cells, cDNA was prepared and gene rearrangements were amplified in nested 
PCR reactions72. IGH gene rearrangements in BCP-ALL samples were determined as part of the diagnostic 
work-up73. Sequences were analyzed with ImMunoGeneTics (IMGT) information system (http://imgt.cines.fr/)74. 
All sequence data have been deposited in GenBank (accession numbers KP771015 - KP771662).
IGH locus contraction was studied with 3D DNA FISH as described previously (details in Supplementary 
Methods)44,46,47.
Gene expression profiling. Microarray analysis was performed on 3 biological replicates of pro-B 
and pre-BI subsets that were bulk-sorted from fetal BM, and compared with previously described pro-B and 
pre-BI subsets from pediatric donors (details provided in Expanded View; ArrayExpress accession number 
E-MTAB-1422)44. Gene networks and canonical pathways representing key genes were identified using Ingenuity 
Figure 6. Protein expression levels in B-cell progenitors. (A) TdT, (B) IL-7Rα , (C) Ki-67, (D) FLT. Graphs 
represent merged data from 3–5 fetal BM (aged 15–19 weeks) and 3–6 pediatric BM samples (aged 7 years) as 
determined by flow cytometry analysis. Immature-B cells of pediatric BM were included as a biological negative 
control. In each plot, the indicated median fluorescence intensities (MFI) are shown as the averages of the 
individual donors with standard error of mean (SEM). Statistics were performed with an unpaired t-test on MFI 
values from individual donors; *p < 0.05, **p < 0.01.
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Pathways Analysis (www.ingenuity.com) following criteria of fold change > 1.5 and p < 0.05 in differences in gene 
expression. Gene expression was confirmed with specific RQ-PCR assays (see Supplementary Methods).
Statistics. Statistical significance was calculated by a non-parametric Mann-Whitney U test, an unpaired 
t-test, χ 2 test or one-way ANOVA as indicated in the Figure legends. P values  < 0.05 were considered as signifi-
cant. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; ns, not significant.
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